Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants.

Frontiers in cellular and infection microbiology - 1 Jan 2023

Liu Zongming, Li Jiaxuan, Pei Shanshan, Lu Ying, Li Chaonan, Zhu Jiajie, Chen Ruyi, Wang Di, Sun Jingbo, Chen Keda

Abstract excerpt

The rapid evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to the emergence of new variants with different genetic profiles, with important implications for public health. The continued emergence of new variants with unique genetic features and potential changes in biological properties poses significant challenges to public health strategies, vaccine development, and therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to COVID-19 Clinical Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CRISPR and Genetic Engineering

Share to Mutation

Share to Public Health

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Source

Open in PubMed Open full text

Identifiers

PMID: 38156316
DOI: 10.3389/fcimb.2023.1297078
PMCID: PMC10752979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants.PMID 38156316Read ↗

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.Semantic proximity Read ↗

The Newly Detected B.1.1.529 (Omicron) Variant of SARS-CoV-2 With Multiple Mutations Implications for transmission, diagnostics, therapeutics, and immune evasionSemantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again?Semantic proximity Read ↗

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and preventionSemantic proximity Read ↗

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read ↗

Global Surveillance and Biological Characterization of the SARS-CoV-2 NB.1.8.1 Variant: An Emerging VUM Lineage Under ScrutinySemantic proximity Read ↗

Emerging SARS-CoV-2 variants: Why, how, and what's next?Semantic proximity Read ↗

Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.Semantic proximity Read ↗

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the hostSemantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.